학술논문
Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial
Document Type
Article
Author
Corboy, J.R.; Seale, R.; Engebretson, E.; Fox, R.J.; Kister, I.; Cutter, G.R.; Morgan, C.J.; Gustafson, T.; Miller, A.E.; Bourdette, D.; Yadav, V.; Goodman, A.; Racke, M.; Fallis, R.; Tornatore, C.; Goldman, M.; Kannan, M.; Sriram, S.; Berger, J.; Cross, A.; Rammohan, K.; Xia, Z.; Leist, T.; Lynch, S.; Klawiter, E.; Amezcua, L.; Bowen, J.
Source
In: The Lancet Neurology . (The Lancet Neurology, July 2023, 22(7):568-577)
Subject
Language
English
ISSN
14744465
14744422
14744422